Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2006 1
2008 1
2009 1
2010 2
2014 1
2015 1
2016 1
2018 3
2019 1
2022 2
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis.
Cordova RA, Misra J, Amin PH, Klunk AJ, Damayanti NP, Carlson KR, Elmendorf AJ, Kim HG, Mirek ET, Elzey BD, Miller MJ, Dong XC, Cheng L, Anthony TG, Pili R, Wek RC, Staschke KA. Cordova RA, et al. Among authors: staschke ka. Elife. 2022 Sep 15;11:e81083. doi: 10.7554/eLife.81083. Elife. 2022. PMID: 36107759 Free PMC article.
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells.
Calvo V, Zheng W, Adam-Artigues A, Staschke KA, Huang X, Cheung JF, Nobre AR, Fujisawa S, Liu D, Fumagalli M, Surguladze D, Stokes ME, Nowacek A, Mulvihill M, Farias EF, Aguirre-Ghiso JA. Calvo V, et al. Among authors: staschke ka. Clin Cancer Res. 2023 Dec 15;29(24):5155-5172. doi: 10.1158/1078-0432.CCR-23-1427. Clin Cancer Res. 2023. PMID: 37982738 Free PMC article.
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors.
Stokes ME, Calvo V, Fujisawa S, Dudgeon C, Huang S, Ballal N, Shen L, Gasparek J, Betzenhauser M, Taylor SJ, Staschke KA, Rigby AC, Mulvihill MJ, Bose N, Lightcap ES, Surguladze D. Stokes ME, et al. Among authors: staschke ka. Clin Cancer Res. 2023 Dec 1;29(23):4870-4882. doi: 10.1158/1078-0432.CCR-23-1182. Clin Cancer Res. 2023. PMID: 37733811 Free PMC article.
GCN2 is required to maintain core body temperature in mice during acute cold.
Levy JL, Mirek ET, Rodriguez EM, Zalma B, Burns J, Jonsson WO, Sampath H, Staschke KA, Wek RC, Anthony TG. Levy JL, et al. Among authors: staschke ka. Am J Physiol Endocrinol Metab. 2023 Nov 1;325(5):E624-E637. doi: 10.1152/ajpendo.00181.2023. Epub 2023 Oct 4. Am J Physiol Endocrinol Metab. 2023. PMID: 37792040 Free PMC article.
Activation of Gcn2 by small molecules designed to be inhibitors.
Carlson KR, Georgiadis MM, Tameire F, Staschke KA, Wek RC. Carlson KR, et al. Among authors: staschke ka. J Biol Chem. 2023 Apr;299(4):104595. doi: 10.1016/j.jbc.2023.104595. Epub 2023 Mar 8. J Biol Chem. 2023. PMID: 36898579 Free PMC article.
Asparagine bioavailability regulates the translation of MYC oncogene.
Srivastava S, Jiang J, Misra J, Seim G, Staschke KA, Zhong M, Zhou L, Liu Y, Chen C, Davé U, Kapur R, Batra S, Zhang C, Zhou J, Fan J, Wek RC, Zhang J. Srivastava S, et al. Among authors: staschke ka. Oncogene. 2022 Oct;41(44):4855-4865. doi: 10.1038/s41388-022-02474-9. Epub 2022 Oct 1. Oncogene. 2022. PMID: 36182969 Free PMC article.
Adapting to cell stress from inside and out.
Staschke KA, Wek RC. Staschke KA, et al. Nat Cell Biol. 2019 Jul;21(7):799-800. doi: 10.1038/s41556-019-0354-x. Nat Cell Biol. 2019. PMID: 31263267 No abstract available.
Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondii.
Augusto L, Martynowicz J, Staschke KA, Wek RC, Sullivan WJ Jr. Augusto L, et al. Among authors: staschke ka. Antimicrob Agents Chemother. 2018 Oct 24;62(11):e01442-18. doi: 10.1128/AAC.01442-18. Print 2018 Nov. Antimicrob Agents Chemother. 2018. PMID: 30181373 Free PMC article.
26 results